Informa Pharma Intelligence

Connecting the Dots for Clinical Trial Recruitment

This super-short animated video (under two minutes) explains the concept behind Citeline Connect, an innovative approach to patient recruitment. Using an industry-first model based on collaboration vs. competition, Citeline Connect is a patient referral network and platform that brings together all recruitment stakeholders—trial sponsors, recruitment partners, healthcare companies, and patient/disease advocacy groups—to better match patients to trials.

The tagline “connecting the dots” reinforces the concept that Citeline Connect technology bridges the gap that previously existed between patient referrals and trial sites. As the video illustrates, with traditional recruitment methods many patients fall through the cracks. Citeline Connect, however, uses detailed pre-screener functionality to ensure that only qualified patients are referred.

Our video has been used as both an educational and a sales tool, to great success. The sponsor used the platform and its network to meet diversity recruitment goals for its Phase 3 COVID-19 vaccine trial, recovering from a 72% decline in non-white randomizations. In just 32 days, network partners delivered nearly 600 randomizations, representing 20% to 25% of the sponsor’s daily randomizations.

The video can be viewed here: https://trialscope.wistia.com/medias/jt71h63oni.

Informa Pharma Intelligence Team:
Animator: Juan Rodriguez

Ads

You May Also Like

PM360 Greatest Creators Showcase 2020 Selection Proximyl Health

Proximyl Health, An MJH Life Sciences Company Athenex Oncology “Nevery-day” Chemotherapy-induced peripheral neuropathy (CIPN) ...

PM360 Greatest Creators Showcase 2023 Selection Inhance Digital and ET Global

Inhance Digital and ET Global AstraZeneca and Amgen TSLP Asthma Interactive Learning Experience AstraZeneca ...

PM360 2021 Innovative Company CureClick

CureClick Nico Coetzee, Chief Marketing Officer nico@cureclick.com CureClick has successfully applied several never before ...